Aratana views itself as the partner of choice in the companion animal market. We have assembled a deep and experienced team of executives and experts in the companion animal industry whose sole focus is to identify and develop innovative therapeutics for the pet market.
A critical element to realizing this goal is Aratana’s ability to license compounds for development as pet therapeutics from forward-thinking biotech and pharmaceutical companies.
Aratana brings to the table an expertise in managing companion animal drug development, offering biotech and pharma companies the potential to gain a previously unrealized revenue stream through licensing and royalties. What’s more, regulatory approval for an animal drug can be shorter than the same drug for human health, opening the potential to realize those revenues while the drug awaits regulatory approval for the human application.
Capitalize on your companion animal strategy now with Aratana today.